Related Experiment Video
Updated: Aug 6, 2026

Optimization of Processing Technology for Tiebangchui with Zanba Based on CRITIC Combined with Box-Behnken Response Surface Method
Published on: May 12, 2023
BO-653. Chugai
1AtheroGenics Inc, 8995 Westside Parkway, Alpharetta, GA 30004, USA. Cmeng@atherogenics.com
Abstract:
BO-653 is an antioxidant under development by Chugai for the potential treatment of atherosclerosis and the prevention of restenosis. By November 2001, BO-653 was in phase II trials for restenosis in post-percutaneous transluminal coronary angioplasty in the US, and by April 2002, the compound was in phase I trials for the same indication in Japan.
Related Concept Videos
Dimensional Analysis
Conversion Factors and Dimensional Analysis
The unit...
Acids, Bases and Neutralization Reactions
Electron Affinity
Bond Energies and Bond Lengths
Titration Calculations: Weak Acid - Strong Base
For the titration of 25.00 mL of 0.100 M CH3CO2H with 0.100 M NaOH, the reaction can be represented as:
Electrolysis

